Walleye Capital LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 68 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$4,050,676
+1.8%
373,6820.0%0.01%
-28.6%
Q2 2023$3,979,713
+497.6%
373,682
+485.8%
0.01%
+40.0%
Q1 2023$665,915
+2.2%
63,7850.0%0.01%
-16.7%
Q4 2022$651,883
+1.7%
63,7850.0%0.01%0.0%
Q3 2022$641,000
+1.1%
63,7850.0%0.01%
-29.4%
Q2 2022$634,000
+0.6%
63,7850.0%0.02%0.0%
Q1 2022$630,00063,7850.02%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$6851.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,482,836$15,2440.42%
MMCAP International Inc. SPC 400,000$4,088,0000.42%
CANTOR FITZGERALD, L. P. 1,422,204$14,5570.31%
KIM, LLC 500,000$5,1400.28%
Spartan Fund Management Inc. 74,485$7630.28%
Saba Capital Management, L.P. 1,791,845$18,384,3300.25%
Atalaya Capital Management LP 125,000$1,285,0000.23%
Radcliffe Capital Management, L.P. 555,355$5,697,9420.18%
Exos TFP Holdings LLC 62,500$638,7500.18%
View complete list of BIOPLUS ACQUISITION CORP shareholders